培菲替尼氢溴酸盐  98%

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

件 库存{{model.attbuying.number}}件
包装规格:25mg 100mg in glass bottle
产品简介:一种具有口服活性的 JAK 抑制剂,对 JAK1、JAK2、JAK3 和 Tyk2 的 IC50 值分别为 3.9、5.0、0.7 和 4.8 nM。
靶点:JAK3:0.7 nM (IC50); JAK1:3.9 nM (IC50); Tyk2:4.8 nM (IC50); JAK2:5 nM (IC50).
体外研究:Peficitinib hydrobromide (0-100 nM; 3 days) inhibits IL-2-induced T cell proliferation in a concentration-dependent manner. Peficitinib hydrobromide (10-1000 nM) inhibits IL-2-induced STAT5 phosphorylation in a concentration-dependent manner with a mean IC50 of 124 nM in rat whole blood, and inhibits STAT5 phosphorylation with a mean IC50 of 127 nM in human lymphocytes.
体内研究:Peficitinib hydrobromide (1-30 mg/kg; p.o.; once daily for 24 days) shows dose-dependent efficacy both in prophylactic and therapeutic dosing regimens in an adjuvant-induced arthritis rat model.
细胞实验:Cell Proliferation Assay Cell Line:Splenocytes from male Lewis rats Concentration:0-100 nM Incubation Time:3 days Result:Inhibited IL-2-induced T cell proliferation in a concentration-dependent manner with an IC50 of 10 nM.
动物实验:Animal Model: Seven-weeks-old female Lewis rats, adjuvant-induced arthritis (AIA) model. Dosage:1, 3, 10, and 30 mg/kg. Administration:Oral administration, once daily for 24 days. Result:Significantly inhibited the increase in paw volume at doses of 1 mg/kg or greater with an ED50 value of 2.7 mg/kg (95% confidence interval: 1.5–4.2 mg/kg). Significantly reduced the bone destruction score at 10 mg/kg or greater and almost fully ameliorated both paw swelling and bone destruction scores at 30 mg/kg.
保存条件:-20°C
注意事项:1、为了您的安全和健康,请穿实验服并戴一次性手套操作。 2、以上信息仅做参考交流之用。